PDS Biotechnology Corporation Made Big Gain

PDS Biotechnology Corporation (PDSB:NASDAQ) rocketted at $7.27, a gain of 26.7%. On Wed, May 19, 2021, PDSB:NASDAQ hit a New 2-Week High of $5.74. The stock got featured on our News Catalysts scanner on Thu, May 20, 2021 at 08:32 AM in the 'BIOTECH' category. From Wed, May 05, 2021, the stock recorded 60.00% Up Days and 45.45% Green Days

The stock spiked on Thu, Mar 11, 2021 at $7.07 with a volume of 45M+.

About PDS Biotechnology Corporation (PDSB:NASDAQ)

Edge Therapeutics Inc operates as a clinical stage biotechnology company, principally involved in drug discovery in the United States. Its core objective lies in the development and commercialization of therapies for serious unmet medical conditions, especially neurological disorders in the hospital setting. The company is currently evaluating EG-1962, its lead product candidate, in the Phase 3 NEWTON 2 study in adult patients with aneurysmal subarachnoid hemorrhage (aSAH). Edge uses its trademark platform known as Precisa, which enables the creation of polymer-based therapeutics capable of delivering directly to the site of injury, without affecting other areas of the body resulting in side-effects.